BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 22613505)

  • 21. T2*-weighted imaging in the assessment of the non-perfused volume of uterine fibroids following magnetic resonance-guided high-intensity focused ultrasound ablation.
    Liu J; Wei J; Keserci B; Zhang J; Yang X; Wang X
    Int J Gynaecol Obstet; 2016 Jan; 132(1):100-2. PubMed ID: 26475075
    [No Abstract]   [Full Text] [Related]  

  • 22. Volumetric feedback ablation of uterine fibroids using magnetic resonance-guided high intensity focused ultrasound therapy.
    Voogt MJ; Trillaud H; Kim YS; Mali WP; Barkhausen J; Bartels LW; Deckers R; Frulio N; Rhim H; Lim HK; Eckey T; Nieminen HJ; Mougenot C; Keserci B; Soini J; Vaara T; Köhler MO; Sokka S; van den Bosch MA
    Eur Radiol; 2012 Feb; 22(2):411-7. PubMed ID: 21901565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: A systematic review and meta-analysis.
    Verpalen IM; Anneveldt KJ; Nijholt IM; Schutte JM; Dijkstra JR; Franx A; Bartels LW; Moonen CTW; Edens MA; Boomsma MF
    Eur J Radiol; 2019 Nov; 120():108700. PubMed ID: 31634683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Usefulness of the Microbubble Contrast Agent SonoVue in Enhancing the Effects of High-Intensity Focused Ultrasound for the Treatment of Adenomyosis.
    Jingqi W; Lu Z; Jun Z; Yuhong M; Wei Y; Lifeng R; Chengbing J; Dobromir DD; Hui Z; Kun Z
    J Ultrasound Med; 2018 Dec; 37(12):2811-2819. PubMed ID: 29689636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of ultrasound-guided high intensity focused ultrasound ablating uterine fibroids with hyperintense on T2-weighted MR imaging.
    Zhao WP; Chen JY; Zhang L; Li Q; Qin J; Peng S; Li KQ; Wang ZB; Chen WZ
    Eur J Radiol; 2013 Jan; 82(1):e43-9. PubMed ID: 23000188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbubble contrast agent SonoVue combined with oxytocin improves the efficiency of high-intensity focused ultrasound ablation for adenomyosis.
    Yao R; Zhao W; Gao B; Hu J; Wang T
    Int J Hyperthermia; 2021; 38(1):1601-1608. PubMed ID: 34763594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term Efficacy of Fibroid Devascularization with Ultrasound-Guided High-Intensity Focused Ultrasound.
    Zhou Y; Chen P; Ji X; Sun T; Li Y; Yuan J; Chen Y; Xiong Y; Wang Y
    Acad Radiol; 2024 May; 31(5):1931-1939. PubMed ID: 37980220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive Value of Quantitative Uterine Fibroid Perfusion Parameters From Contrast-Enhanced Ultrasound for the Therapeutic Effect of High-Intensity Focused Ultrasound Ablation.
    Wang YJ; Zhang PH; Zhang R; An PL
    J Ultrasound Med; 2019 Jun; 38(6):1511-1517. PubMed ID: 30286521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of fibroid ablation rates using radio frequency or high-intensity focused ultrasound.
    Meng X; He G; Zhang J; Han Z; Yu M; Zhang M; Tang Y; Fang L; Zhou X
    Cardiovasc Intervent Radiol; 2010 Aug; 33(4):794-9. PubMed ID: 20544227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Volumetric MR-guided high-intensity focused ultrasound ablation with a one-layer strategy to treat large uterine fibroids: initial clinical outcomes.
    Kim YS; Kim JH; Rhim H; Lim HK; Keserci B; Bae DS; Kim BG; Lee JW; Kim TJ; Choi CH
    Radiology; 2012 May; 263(2):600-9. PubMed ID: 22403170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance-guided high-intensity focused ultrasound of uterine fibroids: whole-tumor quantitative perfusion for prediction of immediate ablation response.
    Li C; Jin C; Liang T; Li X; Wang R; Zhang Y; Yang J
    Acta Radiol; 2020 Aug; 61(8):1125-1133. PubMed ID: 31779469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MR-guided HIFU treatment of symptomatic uterine fibroids using novel feedback-regulated volumetric ablation: effectiveness and clinical practice.
    Ruhnke H; Eckey T; Bohlmann MK; Beldoch MP; Neumann A; Agic A; Hägele J; Diedrich K; Barkhausen J; Hunold P
    Rofo; 2013 Sep; 184(10):983-91. PubMed ID: 23884908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uterine fibroids: semiquantitative perfusion MR imaging parameters associated with the intraprocedural and immediate postprocedural treatment efficiencies of MR imaging-guided high-intensity focused ultrasound ablation.
    Kim YS; Kim BG; Rhim H; Bae DS; Lee JW; Kim TJ; Choi CH; Lee YY; Lim HK
    Radiology; 2014 Nov; 273(2):462-71. PubMed ID: 24988436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic contrast-enhanced magnetic resonance imaging predicts immediate therapeutic response of magnetic resonance-guided high-intensity focused ultrasound ablation of symptomatic uterine fibroids.
    Kim YS; Lim HK; Kim JH; Rhim H; Park BK; Keserci B; Köhler MO; Bae DS; Kim BG; Lee JW; Kim TJ; Sokka S; Lee JH
    Invest Radiol; 2011 Oct; 46(10):639-47. PubMed ID: 21654495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic Resonance Imaging Parameters in Predicting the Treatment Outcome of High-intensity Focused Ultrasound Ablation of Uterine Fibroids With an Immediate Nonperfused Volume Ratio of at Least 90.
    Keserci B; Duc NM
    Acad Radiol; 2018 Oct; 25(10):1257-1269. PubMed ID: 29525424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility, Safety, and Efficacy of Accurate Uterine Fibroid Ablation Using Magnetic Resonance Imaging-Guided High-Intensity Focused Ultrasound With Shot Sonication.
    Xu Y; Fu Z; Yang L; Huang Z; Chen WZ; Wang Z
    J Ultrasound Med; 2015 Dec; 34(12):2293-303. PubMed ID: 26518278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The predictive value of quantitative DCE metrics for immediate therapeutic response of high-intensity focused ultrasound ablation (HIFU) of symptomatic uterine fibroids.
    Wei C; Fang X; Wang CB; Chen Y; Xu X; Dong JN
    Abdom Radiol (NY); 2018 Aug; 43(8):2169-2175. PubMed ID: 29204677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic dose and long-term efficacy of high-intensity focused ultrasound ablation for different types of uterine fibroids based on signal intensity on T2-weighted MR images.
    Wang Y; Gong C; He M; Lin Z; Xu F; Peng S; Zhang L
    Int J Hyperthermia; 2023; 40(1):2194594. PubMed ID: 37011910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of US-guided high-intensity focused ultrasound for treatment of submucosal fibroids.
    Wang W; Wang Y; Wang T; Wang J; Wang L; Tang J
    Eur Radiol; 2012 Nov; 22(11):2553-8. PubMed ID: 22653287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of sonographically guided high-intensity focused ultrasound for symptomatic uterine fibroids: preliminary study of a modified protocol.
    Leung JH; Yu SC; Cheung EC; Wong AS; Tong MM; Ho SS; Leung VY; Ahuja AT
    J Ultrasound Med; 2014 Oct; 33(10):1811-8. PubMed ID: 25253828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.